Pharma

Your Article Summary

See Latest Articles

Four innovative Novartis medicines for cancer, asthma, high blood pressure and wet AMD approved in Japan
Novartis, 01/27/09

Patients in Japan stand to benefit from the approval of four innovative medicines - Tasigna for the treatment of a life-threatening form of leukemia, Xolair for severe asthma, Co-Dio for high blood pressure, and Lucentis for wet age-related macular degeneration (AMD), an eye disease that is a major cause of blindness in people over the age of 50 in Japan.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals